Prostate Cancer - Results from #240

Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors. December 3, 2024

Preoperative Briganti Nomogram Score and Risk of Prostate Cancer Progression After Robotic Surgery Beyond EAU Risk Categories. December 3, 2024

Adipose Tissues Have Been Overlooked as Players in Prostate Cancer Progression. December 3, 2024

Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition. December 2, 2024

Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function. December 2, 2024

Gene-based burden tests of rare germline variants identify six cancer susceptibility genes. December 2, 2024

Germline sequence variation in cancer genes in Rwandan breast and prostate cancer cases. December 2, 2024

Hugo™ Versus daVinci™ Robot-Assisted Radical Prostatectomy: 1-Year Propensity Score-Matched Comparison of Functional and Oncological Outcomes. December 2, 2024

Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming. November 29, 2024

Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer. November 29, 2024

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm. November 29, 2024

Active surveillance follow-up for prostate cancer: from guidelines to real-world clinical practice. November 29, 2024

Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies. November 29, 2024

Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer. November 28, 2024

Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression. November 28, 2024

Phenotypic evaluation of deep learning models for classifying germline variant pathogenicity. November 28, 2024

Nutritional Supplement with Fermented Soy in Patients Under Active Surveillance for Low-Risk or Intermediate-Risk Prostate Cancer: Results from the PRAEMUNE Trial. November 28, 2024

Cross-shaped windows transformer with self-supervised pretraining for clinically significant prostate cancer detection in bi-parametric MRI. November 28, 2024

Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer. November 28, 2024

Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven Seven-Gene Stemness Signature That Predicts Progression. November 27, 2024

Page 13 of 1454